FIELD: medicine. SUBSTANCE: method involves introducing biological substrata into the vitreous body cavity activating cell proliferation. Mixture composed of three ingredients is used as the biological substrata. The first ingredient has autologic retina pigment epithelium cells of rabbit eye (in the amount of 9.1-9.6 102 cells in 0.2 ml of medium). The second ingredient is a natural complex of homologic cytokins produced by lymphocytes (0.1 ml volume with 40 mcg concentration). The third ingredient is plasma fibronectin (0.1 ml volume with 0.5 mcg concentration). EFFECT: improved quality of model. 9 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING PROLIFERATIVE VITREORETINOPATHY | 1999 |
|
RU2175223C2 |
METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY | 2014 |
|
RU2568368C1 |
METHOD FOR THE TREATMENT OF PROLIFERATIVE PROCESSES OF THE POSTERIOR SEGMENT OF THE EYE | 2018 |
|
RU2684927C1 |
METHOD FOR TREATING PROLIFERATIVE VITREORETINOPATHY USING LIPOSOME-ASSOCIATED MELPHALAN IN AN EXPERIMENT | 2021 |
|
RU2772520C1 |
DRAIN FOR TREATING THE CASES OF AMOTIO RETINAE RECURRENCE | 2001 |
|
RU2192822C1 |
METHOD FOR REMOVING INTRAOCULAR FOREIGN BODIES IN DIASCLERAL WAY | 2002 |
|
RU2223076C1 |
METHOD FOR SIMULATING PROLIFERATIVE RETINOPATHY IN RATS | 2014 |
|
RU2558991C1 |
METHOD OF TREATING ENDOPHTHALMITES | 1998 |
|
RU2164115C2 |
METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY IN RATS | 2014 |
|
RU2563368C1 |
METHOD FOR EVALUATING ANTI-INFLAMMATORY ACTIVITY OF CYTOKINETIC AGENTS | 1999 |
|
RU2150113C1 |
Authors
Dates
2000-12-27—Published
1998-10-20—Filed